T-cell-engaging B7-H4/CD3 bispecific Fab-scFv antibody targeting human breast cancer

被引：0
|
作者：
Iizuka, Akira [1 ]
Ashizawa, Tadashi [1 ]
Ohshima, Keiichi [2 ]
Kusuhara, Masatoshi [3 ]
Yamaguchi, Ken [4 ]
Akiyama, Yasuto [1 ]
机构：
[1] Shizuoka Canc Ctr, Res Inst, Dept Immunother, Nagaizumi, Shizuoka, Japan
[2] Shizuoka Canc Ctr, Res Inst, Med Genet Div, Nagaizumi, Shizuoka, Japan
[3] Shizuoka Canc Ctr, Res Inst, Reg Resources Div, Nagaizumi, Shizuoka, Japan
[4] Shizuoka Canc Ctr, Nagaizumi, Shizuoka, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1143
引用
收藏
页码：413 / 413
页数：1
相关论文
共 50 条
  • [1] A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer
    Iizuka, Akira
    Nonomura, Chizu
    Ashizawa, Tadashi
    Kondou, Ryota
    Ohshima, Keiichi
    Sugino, Takashi
    Mitsuya, Koichi
    Hayashi, Nakamasa
    Nakasu, Yoko
    Maruyama, Kouji
    Yamaguchi, Ken
    Akiyama, Yasuto
    CLINICAL CANCER RESEARCH, 2019, 25 (09) : 2925 - 2934
  • [2] Multiformat T-Cell-Engaging Bispecific Antibodies Targeting Human Breast Cancers
    Cao, Yu
    Axup, Jun Y.
    Ma, Jennifer S. Y.
    Wang, Rongsheng E.
    Choi, Seihyun
    Tardif, Virginie
    Lim, Reyna K. V.
    Pugh, Holly M.
    Lawson, Brian R.
    Welzel, Gus
    Kazane, Stephanie A.
    Sun, Ying
    Tian, Feng
    Srinagesh, Shailaja
    Javahishvili, Tsotne
    Schultz, Peter G.
    Kim, Chan Hyuk
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (24) : 7022 - 7027
  • [3] A novel B7-H6/CD3 bispecific IgG-like T cell engaging antibody for the treatment of colorectal cancer.
    Hipp, Susanne
    Zhang, Wei
    Liao, Xiaoyun
    Auguste, Aurelie
    Osswald, Annika
    Bauer, Kathrin
    Walterskirchen, Christian
    Sayedian, Farzaneh H.
    Kellner, Manuela
    Giragossian, Craig
    Voynov, Vladimir
    Nixon, Andrew E.
    Adam, Paul J.
    CANCER RESEARCH, 2021, 81 (13)
  • [4] Construction, expression and identification of bispecific antibody for targeting CD3 and B7-H3.
    Zhang, K.
    Gui, F.
    Wang, J.
    Pan, Y.
    Yang, X.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1743 - 1743
  • [5] Preclinical Characterization of AMG 330, a CD3/CD33-Bispecific T-Cell-Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia
    Friedrich, Matthias
    Henn, Anja
    Raum, Tobias
    Bajtus, Monika
    Matthes, Katja
    Hendrich, Larissa
    Wahl, Joachim
    Hoffmann, Patrick
    Kischel, Roman
    Kvesic, Majk
    Slootstra, Jerry W.
    Baeuerle, Patrick A.
    Kufer, Peter
    Rattel, Benno
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (06) : 1549 - 1557
  • [6] A Probody T Cell-Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity
    Boustany, Leila M.
    LaPorte, Sherry L.
    Wong, Laurie
    White, Clayton
    Vinod, Veena
    Shen, Joel
    Yu, Wendy
    Koditek, David
    Winter, Michael B.
    Moore, Stephen J.
    Mei, Li
    Diep, Linnea
    Huang, Yuanhui
    Liu, Shouchun
    Vasiljeva, Olga
    West, Jim
    Richardson, Jennifer
    Irving, Bryan
    Belvin, Marcia
    Kavanaugh, W. Michael
    CANCER RESEARCH, 2022, 82 (22) : 4288 - 4298
  • [7] JNJ-78306358, a first-in-class bispecific T cell engaging antibody targeting CD3 and HLA-G
    Obermajer, Natasa
    Zwolak, Adam
    van de Ven, Kelly
    Versmissen, Shana
    Menard, Krista
    Rogers, Katharine
    Petley, Ted
    Weinstock, Dan
    Aligo, Jason
    Patel, Jaymala
    Tian, Ken
    Angelillo, Lorraine
    Yi, Fang
    Jarantow, Stephen
    Schutsky, Keith
    Hamuro, Yoshitomo
    Arias, Diana Alvarez
    Buyens, Kristel
    Yao, Tsun-Wen Sheena
    Torti, Vince
    Brajic, Aleksandra
    Geist, Brian
    van Heerden, Marjolein
    Chu, Gerald
    Verbist, Bie
    Ongenaert, Mate
    Hasler, Julien
    Packman, Kathryn
    Shenton, Jacintha
    Lenox, Laurie
    Clawson, Jacalyn
    Brown, Regina J.
    Lauring, Josh
    Greger, James G.
    Brehmer, Dirk
    Singh, Sanjaya
    Lorenzi, Matthew, V
    Laquerre, Sylvie
    ISCIENCE, 2025, 28 (03)
  • [8] B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration
    Kim, Nah Ihm
    Park, Min Ho
    Kweon, Sun-Seog
    Lee, Ji Shin
    PATHOBIOLOGY, 2020, 87 (03) : 179 - 192
  • [9] Initial Clinical Activity and Safety of BFCR4350A, a FcRH5/CD3 T-Cell-Engaging Bispecific Antibody, in Relapsed/Refractory Multiple Myeloma
    Cohen, Adam D.
    Harrison, Simon J.
    Krishnan, Amrita
    Fonseca, Rafael
    Forsberg, Peter A.
    Spencer, Andrew
    Berdeja, Jesus G.
    Laubach, Jacob P.
    Li, Mengsong
    Choeurng, Voleak
    Vaze, Anjali
    Samineni, Divya
    Sumiyoshi, Teiko
    Cooper, James
    Fine, Bernard M.
    Trudel, Suzanne
    BLOOD, 2020, 136
  • [10] Strengthening of antitumor effects in breast cancer from a novel B7-H4-and CD3-targeting bispecific antibody by an oncolytic virus
    Tang, Jing
    Ma, Xuqian
    Chen, Xin
    Feng, Mingqian
    Jin, Xin
    Wang, Ke
    Wan, Jixi
    Zhu, Xianmin
    Xie, Rong
    Dong, Shuang
    Hu, Sheng
    Jiang, Hui
    Xie, Conghua
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (14)
12345